MARGOLIN YAEL reported 1 transaction at POINT BIOPHARMA GLOBAL INC.
Review the transaction codes below to understand the nature of each event.
Filed: 12/27/2023ACC: 0001104659-23-129766
-97.07K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
97.07K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.71K
Price / share
—
Trade value
—
% of position
New position
12/27/2023
1.71K→0.00
Total
Net shares
−1.71K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/27/2023 | D · Disposition | −1.71K | — | — | New position | 1.71K | 0.00 |
| Total | −1.71K | $0.00 | ||||||
Derivative Transactions3
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
25K shares
Shares
−25K
Strike price
8.47
Held after
0.00
Exercisable
—
12/27/2023
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
25.61K shares
Shares
−25.61K
Strike price
8.31
Held after
0.00
Exercisable
—
12/27/2023
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
44.75K shares
Shares
−44.75K
Strike price
9.12
Held after
0.00
Exercisable
—
12/27/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock25K shares | 12/27/2023 | D · Disposition | −25K | 8.47 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock25.61K shares | 12/27/2023 | D · Disposition | −25.61K | 8.31 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock44.75K shares | 12/27/2023 | D · Disposition | −44.75K | 9.12 | — | 0.00 |